pimobendan has been researched along with sildenafil citrate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, Y; Imai, Y; Morita, T; Nagai, R; Nakajima, T; Sahara, M; Takahashi, T; Yao, A | 1 |
| Fukayama, T; Fukushima, R; Goya, S; Nakata, TM; Tanaka, R; Yoshiyuki, R | 1 |
| Broens, EM; Dobak, TP; Toom, ML; Valtolina, C | 1 |
| Nakata, TM; Shimada, K; Suzuki, K; Tanaka, R; Uemura, A | 1 |
| Grint, KA; Kellihan, HB; Stepien, RL; Tjostheim, SS | 1 |
| Gabrielsson, J; Jirstrand, M; Martel, E; Pairet, N; Scheuerer, S; Wallman, M | 1 |
1 review(s) available for pimobendan and sildenafil citrate
| Article | Year |
|---|---|
New insights in the treatment strategy for pulmonary arterial hypertension.
Topics: Anticoagulants; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nicorandil; Nitric Oxide Donors; Oxygen Inhalation Therapy; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyridazines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2006 |
5 other study(ies) available for pimobendan and sildenafil citrate
| Article | Year |
|---|---|
Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Nicorandil; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 5 Inhibitors; Pyridazines; Rats, Wistar; Recovery of Function; Severity of Illness Index; Sildenafil Citrate; Vasodilator Agents; Ventricular Dysfunction, Right; Ventricular Function, Right | 2015 |
Interstitial pneumonia and pulmonary hypertension associated with suspected ehrlichiosis in a dog.
Topics: Animals; Antiparasitic Agents; Dog Diseases; Dogs; Doxycycline; Ehrlichiosis; Heart Failure; Hypertension, Pulmonary; Lung Diseases, Interstitial; Male; Pyridazines; Radiography, Thoracic; Sildenafil Citrate; Treatment Outcome; Vasodilator Agents | 2016 |
Contrasting Effects of Inhibition of Phosphodiesterase 3 and 5 on Cardiac Function and Interstitial Fibrosis in Rats With Isoproterenol-Induced Cardiac Dysfunction.
Topics: Animals; Arrhythmias, Cardiac; Collagen Type I; Collagen Type III; Disease Models, Animal; Fibrosis; Isoproterenol; Male; Myocardium; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 5 Inhibitors; Pyridazines; Rats, Wistar; Risk Assessment; Sildenafil Citrate; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Effect of sildenafil and pimobendan on intracardiac heartworm infections in four dogs.
Topics: Animals; Antigens, Helminth; Arsenicals; Dirofilaria; Dirofilariasis; Dog Diseases; Dogs; Female; Filaricides; Male; Pyridazines; Sildenafil Citrate; Triazines; Tricuspid Valve; Vasodilator Agents | 2019 |
An Integrative Approach for Improved Assessment of Cardiovascular Safety Data.
Topics: Animals; Biomarkers, Pharmacological; Blood Pressure; Cardiotoxicity; Cardiovascular Agents; Heart Rate; Ivabradine; Male; Phenethylamines; Pyridazines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfonamides | 2021 |